Stay updated with breaking news from Jack Anders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) hit a new 52-week high on Thursday . The company traded as high as $33.81 and last traded at $33.75, with a volume of 72758 shares changing hands. The stock had previously closed at $33.30. Analysts Set New Price Targets A number of research analysts […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.82) by ($0.10), Briefing.com reports. Revolution Medicines had a negative net margin of 744.36% and a negative return on equity of 36.79%. The business had […]
Victory Capital Management Inc. trimmed its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 5.9% in the 1st quarter, HoldingsChannel reports. The firm owned 45,410 shares of the company’s stock after selling 2,860 shares during the quarter. Victory Capital Management Inc.’s holdings in Revolution Medicines were worth $984,000 as of its most recent […]
HC Wainwright reissued their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a report issued on Wednesday morning, Benzinga reports. HC Wainwright currently has a $32.00 price objective on the stock. HC Wainwright also issued estimates for Revolution Medicines’ Q2 2023 earnings at ($0.81) EPS, Q3 2023 earnings at ($0.91) EPS, […]
Revolution Medicines (NASDAQ:RVMD – Free Report) had its price target increased by Needham & Company LLC from $31.00 to $35.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. They currently have a buy rating on the stock. A number of other research analysts have also recently commented on the company. JPMorgan Chase […]